We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Magnetic Needle Performs Less Invasive, More Precise Surgery and Diagnostic Tests

By LabMedica International staff writers
Posted on 25 Apr 2022
Print article
Image: MPACT-Needle (Photo courtesy of Johns Hopkins)
Image: MPACT-Needle (Photo courtesy of Johns Hopkins)

A tiny, untethered needle can enter the body through an incision no larger than a pin prick to perform biopsies, suture wounds, and even deliver cancer-fighting chemotherapy directly to tumors. Controlled by externally applied magnetics forces—no attached, guiding wires, or human or robotic hands—these miniscule tools promise a future of more precise, safer, and far less invasive surgery, experts say. However, as devices get smaller, so does their response to the magnetic forces that cause them to move and steer their course. Now, researchers have a solution: a surgical needle equipped with small magnets inside that, when stimulated by the externally applied forces, slip from one end of the needle to another, tapping against a rigid plate and supplying ample force to penetrate tissue.

In a study, a team of researchers at the Johns Hopkins Whiting School of Engineering (Baltimore, MD, USA) have demonstrated for the first time that untethered magnetic needles can be forceful enough to accomplish surgery. The researchers call their device the "Pulse Actuated Collisions for Tissue-penetrating Needle," or MPACT-Needle. For their experiments, the team connected a slender thread of suturing material to the needle, using a joystick connected to a computer to deliver commands that enabled the MPACT-Needle to perform surgical suturing on a sample rabbit cornea.

The team's next step is to develop better, more accurate motion-control algorithms equipped with imaging modalities to precisely control the movement of the device, making surgeries and procedures safer. The researchers believe that if the technology becomes successful, their new magnetic needles would make it possible to access hard-to-reach, delicate areas of the body, such as the bile duct, to deliver drugs directly to tumors, extract biopsy samples, or suture a wound rapidly and effectively to stem internal bleeding.

"These extremely small tools have the potential to revolutionize medicine, but as anyone who has played with magnets knows, size is important," said Axel Krieger, an assistant professor of mechanical engineering at Johns Hopkins Whiting School of Engineering. "The smaller the surgical tool, the less invasive the surgery, but also the weaker the device's response to magnetic force. One of the biggest challenges facing us is how to make sure that these mini-tools can be moved with enough force to penetrate tissue and do the job they are there to do."

"We proved that these tiny magnetic needles can have strong enough forces to perform delicate surgery with limited invasiveness," said study leader Onder Erin, a postdoctoral fellow in mechanical engineering at Johns Hopkins. "I can envision a time when our device will also be used to perform biopsies, and even deliver therapeutics and chemotherapy directly to tumors."

Related Links:
Johns Hopkins Whiting School of Engineering 

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: Professor Nicole Strittmatter (left) and first author Wei Chen stand in front of the mass spectrometer with a tissue sample (Photo courtesy of Robert Reich/TUM)

Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication

Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more

Molecular Diagnostics

view channel
Image: Macrophages infected with mycobacterium tuberculosis (Photo courtesy of MIT)

New Molecular Label to Help Develop Simpler and Faster Tuberculosis Tests

Tuberculosis (TB), the deadliest infectious disease globally, is responsible for infecting an estimated 10 million people each year and causing over 1 million deaths annually. While chest X-rays and molecular... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.